| Pao VY, Lee GA, Taylor S, et al.
The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers. [JOURNAL ARTICLE]
AIDS 2009 Nov 3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Quaranta S, Woloch C, Paccou A, et al.
Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples. [JOURNAL ARTICLE]
Ther Drug Monit 2009 Oct 27.
Abstract | Full Citation | Find Related Articles | | Belperio P, Mole L, Boothroyd D, et al.
Trends in uptake of recently approved antiretrovirals within a national healthcare system. [JOURNAL ARTICLE]
HIV Med 2009 Oct 23.
Abstract | Full Citation | Find Related Articles | | Puthanakit T, Chokephaibulkit K, Suntarattiwong P, et al.
THERAPEUTIC DRUG MONITORING OF LOPINAVIR IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN RECEIVING ADULT TABLETS: THERAPEUTIC DRUG MONITORING OF LOPINAVIR TABLETS GIVEN TO CHILDREN. [JOURNAL ARTICLE]
Pediatr Infect Dis J 2009 Oct 24.
Abstract | Full Citation | Find Related Articles | | Elens L, Yombi JC, Lison D, et al.
Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients. [Journal Article]
Pharmacogenomics 2009 Oct; 10(10):1589-97.
Abstract | Full Citation | Find Related Articles | | Fox MP, Ive P, Long L, et al.
High Rates of Survival, Immune Reconstitution and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Oct 15.
Abstract | Full Citation | Find Related Articles | | Nierenberg NE, Thompson GR, Lewis JS, et al.
Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir. [JOURNAL ARTICLE]
Med Mycol 2009 Oct 19.
Abstract | Full Citation | | McArthur MA, Kalu SU, Foulks AR, et al.
TWIN PRETERM NEONATES WITH CARDIAC TOXICITY RELATED TO LOPINAVIR/RITONAVIR THERAPY. [JOURNAL ARTICLE]
Pediatr Infect Dis J 2009 Oct 8.
Abstract | Full Citation | | Young J, Bucher HC, Guenthard HF, et al.
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. [JOURNAL ARTICLE]
Antivir Ther 2009; 14(6):771-779.
Abstract | Full Citation | | Boulanger C, Hollender E, Farrell K, et al.
Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir-Ritonavir in Patients with HIV Infection and Active Tuberculosis. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Oct 6.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
